Search - tctmd.com

Displaying 281 - 300 of 393

Sort: Relevancy | Date

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

News Daily News

Tool May Help Select Patients for Endovascular Stroke Treatment

Todd Neale

May 15, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Daily News

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

Michael O'Riordan

May 12, 2017

News Conference News SCAI 2017

#SoMe for #SciComm? Cardiologists See Value in Social Media, With Some Caveats

L.A. McKeown

May 10, 2017

News Daily News

HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer

Michael O'Riordan

May 10, 2017

Podcast TCTMD Talking Points

Episode 20: TRANSFORM-OCT - OCT Imaging to Evaluate Strut Coverage

May 10, 2017

News Industry News

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

May 09, 2017

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

Presentation SWVS 2017

Heart Valve Dysfunction With ESRD: Options and Expectations

Presenter: Michael J. Reardon

May 06, 2017

News Daily News

Another Observational CTO Study Confirms Procedural Success of PCI but Doesn't Definitively Show Effect on Outcomes

Yael L. Maxwell

May 05, 2017

News Daily News

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

Todd Neale

May 05, 2017

News Daily News

‘Sizeable’ Segment of Public, Even When at High CVD Risk, Feels No Need to Improve Health

Michael O'Riordan

May 04, 2017

News Daily News

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Michael O'Riordan

May 04, 2017

Podcast TCTMD Talking Points

Episode 19: Pragmatic Clinical Trials and the Road Ahead

May 03, 2017

News Daily News

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Michael O'Riordan

April 27, 2017

Advertisement

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Tool May Help Select Patients for Endovascular Stroke Treatment

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

$2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor

#SoMe for #SciComm? Cardiologists See Value in Social Media, With Some Caveats

HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer

Episode 20: TRANSFORM-OCT - OCT Imaging to Evaluate Strut Coverage

Boston Scientific Receives U.S. FDA Approval For Resonate™ Family Of High-Voltage Devices

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Heart Valve Dysfunction With ESRD: Options and Expectations

Another Observational CTO Study Confirms Procedural Success of PCI but Doesn't Definitively Show Effect on Outcomes

More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds

‘Sizeable’ Segment of Public, Even When at High CVD Risk, Feels No Need to Improve Health

High-Volume Surgeons More Likely to Perform Durable Mitral Valve Repairs, Have Better Outcomes

Episode 19: Pragmatic Clinical Trials and the Road Ahead

Thirty-Day Readmission in Acute MI Not Linked With Hospital Care or Clinical Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content